GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development and manufacturing, ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
A research team led by Prof. Sun Chaomin from the Institute of Oceanology of the Chinese Academy of Sciences (IOCAS) has ...
High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary ...
It’s been hypothesized for decades that life on Earth may not have been as “homegrown” as one might think and now, we’re ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...
5don MSN
Machine learning reveals how disordered protein regions contribute to cancer-causing condensates
Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...
All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback